Emory University a
line a aa line

November 29, 2012


Research Extras

See how a new Malaria Research Consortium including Emory, UGA, Georgia Tech, and CDC will use a $19.4 million NIH contract in a “systems biology” approach to determining how malaria parasites interact with human and animal hosts.

Attend the 8th Annual Predictive Health Symposium: Lessons Learned from Contemporary Medicine Friday, Dec. 6, 8 a.m.-6:00 p.m. WHSCAB Auditorium.

Learn how Big Bethel AME Church and the Atlanta Clinical and Translational Science Institute partner on a community diabetes research resource for screening, coaching, and clinical trials.

Read about the new contract to Emory's TravelWell clinic from the National Hansen's Disease Program (NHDP) to treat patients with leprosy. TravelWell is one of only 16 federally supported outpatient clinics to treat patients through the NHDP.

The Emory Parkinson's and Movement Disorders Program will hold a free Screening Day Dec. 7.

Watch a video featuring nursing professor Judith Wold, 2012 CASE award recipient for Georgia professor of the year.





a a

An Antidote for Hypersomnia
Some adults with a disabling, elevated need for sleep, called "primary hypersomnia," have a substance in their cerebrospinal fluid that acts like a sleeping pill. Treatment with the drug flumazenil appears to counteract this unknown "somnogen" and restore alertness. Identifying this substance, which enhances inhibitory chemicals in the nervous system, could help in developing a treatment. Read more...

a a
At-Home Ear Infection Diagnosis

New Alzheimer's Risk Gene Identified
A newly identified genetic variation increases risk for late-onset Azheimer's disease. Although rare, the TREM2 gene adds to a growing list of genes linked to Alzheimer's and provides clues to its cause. The mutation is expressed in microglial cells in the brain and seems to regulate inflammation, suggesting that alterations in these cells, and inflammation, are Alzheimer's risk factors. Read more..

The TREM2 gene is expressed in microglial cells in the brain          
a a
Targeting Inflammation to Treat Depression

iPSC Lab Reprograms Cells for Personalized Medicine and Drug Discovery
Recent advances in induced pluripotent stem cell (iPSC) technology allow researchers to take a patient's skin or blood cells, reprogram them into an immature, embryonic-like state, and differentiate them into specific tissue types. This technology could spearhead personalized medicine, making it possible to test the effects of drugs on patients' cells. Read more...

a a
Saad B. Omer


Saving Children's Lives Through Metabolic Screening, Nutrition, and Research
Emory's Metabolic Genetics Nutrition Program studies 22 known primary metabolic disorders and 30 related conditions recommended for newborn screening. As the only clinic in Georgia to offer complete services for managing metabolic disorders, its geneticists and nutritionists follow up on 5,000 abnormal newborn screening tests and treat 250 children with metabolic disorders annually. Read more...

a a
JAM-A deficient

Exercise is Powerful Antidote to Heart Failure
Heart failure often causes already inactive patients to become even more sedentary, making it difficult to perform even the simplest everyday tasks. This cycle of inactivity and low expectations can lead to muscle atrophy, loss of strength, and deconditioning. Although exercise in heart failure may seem counterintuitive, research shows it can dramatically improve ability and reduce symptom severity. Read more...

Woodruff Health Sciences Center
a a

Link to the Current Issue More Research News Archives Contact Us Holly Korshun David Stephens